Ocugen
Price & Volume
Stats
See more52W Range | $0.34-$2.10 |
Market Cap | $322.4M |
Shares Short | 51M |
Financials
See moreRevenue (12 Mos) | $7.2M |
Revenue Growth (YoY) | 135.3% |
Gross Profit (12 Mos) | -$49.7M |
Diluted EPS | -$0.18 |
News
See moreYahoo Finance • 2 months ago
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid
Yahoo Finance • 10 months ago
Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
Yahoo Finance • 10 months ago
Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST—Modifier Gene Therapy—for Stargardt Disease
Yahoo Finance • 10 months ago
Q3 2023 Ocugen Inc Earnings Call
About
CEO | Dr. Shankar Musunuri M.B.A., Ph.D. |
Address | 11 Great Valley Parkway, Malvern, PA, United States, 19355 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 65 |
